|
LARP1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.564370E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.480400E-01 |
| Normal-vs-Stage2 |
3.388000E-01 |
| Normal-vs-Stage3 |
2.457900E-02 |
| Normal-vs-Stage4 |
1.420180E-02 |
| Stage1-vs-Stage2 |
2.282400E-01 |
| Stage1-vs-Stage3 |
6.258000E-02 |
| Stage1-vs-Stage4 |
6.316100E-02 |
| Stage2-vs-Stage3 |
4.102500E-02 |
| Stage2-vs-Stage4 |
3.313500E-02 |
| Stage3-vs-Stage4 |
8.969000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.200400E-01 |
| Normal-vs-AfricanAmerican |
7.603600E-03 |
| Normal-vs-Asian |
4.268800E-01 |
| Caucasian-vs-AfricanAmerican |
5.598300E-02 |
| Caucasian-vs-Asian |
5.072000E-01 |
| AfricanAmerican-vs-Asian |
7.684300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.480100E-02 |
| Normal-vs-Female |
9.963000E-01 |
| Male-vs-Female |
7.466000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.203170E-04 |
| Normal-vs-Age(41-60Yrs) |
4.306200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.430800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.292200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.860990E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.081600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.516500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.202800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.874200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.937000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.106600E-01 |
| Normal-vs-Grade 2 |
7.584000E-01 |
| Normal-vs-Grade 3 |
1.499020E-01 |
| Normal-vs-Grade 4 |
1.04830000002831E-06 |
| Grade 1-vs-Grade 2 |
6.546800E-01 |
| Grade 1-vs-Grade 3 |
9.440800E-01 |
| Grade 1-vs-Grade 4 |
6.322100E-02 |
| Grade 2-vs-Grade 3 |
1.172450E-01 |
| Grade 2-vs-Grade 4 |
2.00289999996439E-06 |
| Grade 3-vs-Grade 4 |
6.846600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.572300E-02 |
| Normal-vs-ccB subtype |
7.176700E-03 |
| ccA subtype-vs-ccB subtype |
4.36430000000376E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.176800E-01 |
| Normal-vs-N1 |
5.664000E-02 |
| N0-vs-N1 |
4.647400E-01 |
|
|
